Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 6, 2022; 10(28): 10066-10076
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10066
Figure 1
Figure 1 Treatment outcomes. TA: Targeted agent.
Figure 2
Figure 2 Median overall survival in patients with and without targeted agent. A: Progression-free survival older patients with metastatic colorectal cancer (CRC) treated with targeted agents; B: Overall survival of older patients with metastatic CRC treated with targeted agents. TA: Targeted agent.
Figure 3
Figure 3 Overall survival of older patients diagnosed with metastatic colorectal cancer, according to salvage chemotherapy after the failure of first-line chemotherapy.